SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-24-073628
Filing Date
2024-06-14
Accepted
2024-06-14 16:05:34
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A phat-20240331.htm   iXBRL 10-Q/A 1266600
2 EX-31.1 phat-ex31_1.htm EX-31.1 13676
3 EX-31.2 phat-ex31_2.htm EX-31.2 13736
4 EX-32.1 phat-ex32_1.htm EX-32.1 8119
5 EX-32.2 phat-ex32_2.htm EX-32.2 8162
  Complete submission text file 0000950170-24-073628.txt   7559922

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT phat-20240331.xsd EX-101.SCH 1543601
63 EXTRACTED XBRL INSTANCE DOCUMENT phat-20240331_htm.xml XML 1123487
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39094 | Film No.: 241044710
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)